Evidence map›Paper›PMID 26637559›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2016

The NRF2 knockout rat: a new animal model to study endothelial dysfunction, oxidant stress, and microvascular rarefaction.

Jessica R C Priestley, Katie E Kautenburg, Marc C Casati, Bradley T Endres, Aron M Geurts, Julian H Lombard

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 70 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Antioxidant Polyphenols ofAntioxidants (Basel, Switzerland) · 2022
    Article
  13. Recent Advances in the Production of Genome-Edited Rats.International journal of molecular sciences · 2022
    Review
  14. Article
  15. Review
  16. Review
  17. Keap1/Nrf2 Signaling Pathway.Antioxidants (Basel, Switzerland) · 2021
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jessica R C PriestleyDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin; and.
Katie E KautenburgDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin; and.
Marc C CasatiDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin; and.
Bradley T EndresDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin; and.
Aron M GeurtsDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin; and Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin.
Julian H LombardDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin; and jlombard@mcw.edu.
Medical College of Wisconsin · US

Funding

HIGH SALT DIET, ANGIOTENSIN II, AND MICROVESSEL DILATIONR01HL065289 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LOMBARD, JULIAN H · 2000 to 2012
$3.8M
Advanced genetic engineering technology developmentDP2OD008396 · OD · MEDICAL COLLEGE OF WISCONSIN · PI GEURTS, ARON M · 2011 to 2011
$2.3M
Role of Nrf2 in Vascular Antioxidant DefenseR01HL128242 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LOMBARD, JULIAN H · 2016 to 2019
$1.8M
Oxidant Stress in the Nrf2 Knockout RatR21OD018309 · OD · MEDICAL COLLEGE OF WISCONSIN · PI LOMBARD, JULIAN H · 2014 to 2015
$416k
High Salt Diet, Angiotensin II, and Microvessel DilationR56HL065289 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LOMBARD, JULIAN H · 2014 to 2014
$383k
NHLBI NIH HHS R01 HL128242NHLBI NIH HHS R01-HL-65289-12NHLBI NIH HHS R56 HL065289NHLBI NIH HHS R56-HL-65289-13A1NIH HHS DP2 OD008396NIH HHS R21 OD018309NIH HHS R21-OD-018309-01
6 · The paper itself

Abstract

Nuclear factor (erythroid-derived 2)-like-2 (NRF2) is a master antioxidant and cell protective transcription factor that upregulates antioxidant defenses. In this study we developed a strain of Nrf2 null mutant rats to evaluate the role of reduced NRF2-regulated antioxidant defenses in contributing to endothelial dysfunction and impaired angiogenic responses during salt-induced ANG II suppression. Nrf2(-/-) mutant rats were developed using transcription activator-like effector nuclease technology in the Sprague-Dawley genetic background, and exhibited a 41-bp deletion that included the start codon for Nrf2 and an absence of immunohistochemically detectable NRF2 protein. Expression of mRNA for the NRF2-regulated indicator enzymes heme oxygenase-1, catalase, superoxide dismutase 1, superoxide dismutase 2, and glutathione reductase was significantly lower in livers of Nrf2(-/-) mutant rats fed high salt (HS; 4% NaCl) for 2 wk compared with wild-type controls. Endothelium-dependent dilation to acetylcholine was similar in isolated middle cerebral arteries (MCA) of Nrf2(-/-) mutant rats and wild-type littermates fed low-salt (0.4% NaCl) diet, and was eliminated by short-term (3 days) HS diet in both strains. Low-dose ANG II infusion (100 ng/kg sc) reversed salt-induced endothelial dysfunction in MCA and prevented microvessel rarefaction in wild-type rats fed HS diet, but not in Nrf2(-/-) mutant rats. The results of this study indicate that suppression of NRF2 antioxidant defenses plays an essential role in the development of salt-induced oxidant stress, endothelial dysfunction, and microvessel rarefaction in normotensive rats and emphasize the potential therapeutic benefits of directly upregulating NRF2-mediated antioxidant defenses to ameliorate vascular oxidant stress in humans.

Indexed as

MicrocirculationOxidative StressAcetylcholineAngiotensin IIAnimalsAntioxidantsCapillariesEndothelium, VascularGene Knockout TechniquesImmunohistochemistryMiddle Cerebral ArteryNF-E2-Related Factor 2RatsRats, Sprague-DawleyTranslocation, GeneticUp-RegulationAcetylcholineAngiotensin IIAntioxidantsNfe2l2 protein, ratNF-E2-Related Factor 2Vasoconstrictor AgentsVasodilator Agentsangiogenesisangiotensin IIendotheliumnitric oxidenuclear factor (erythroid-derived 2)-like-2salt

Identifiers

PMID26637559
PMCPMC4796617
OpenAlexW2192214170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.